301235.SHE Wuhan Huakang Century Medical Co. Ltd.
- Market cap
- CNY 3.94B
- P/E
- 38.7x
- P/B
- 1.48x
- ROE
- 2.6%
- Dividend yield
- 0.49%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 301235.SHE undervalued?
Graham number301235.SHE trades 59.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Wuhan Huakang Century Medical Co. Ltd. fundamental analysis
No fundamental analysis for Wuhan Huakang Century Medical Co. Ltd. yet.
Wuhan Huakang Century Medical Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Wuhan Huakang Century Medical Co. Ltd.
Wuhan Huakang Century Clean Technology Co., Ltd. provides purification system integration and sale of medical equipment and consumables services in China and internationally. It is also involved in the sale of medical equipment and consumables. In addition, the company offers integrated medical, laboratory integrated, and integrated electronic cleaning services, as well as medical consumables sales; purification system integration operation, and maintenance services. The com…
Full company profileWuhan Huakang Century Medical Co. Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Wuhan Huakang Century Medical Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 602M | 762M | 861M | 1.19B | 1.60B | 1.71B | 2.29B | 2.37B |
| Gross Profit | 215M | 252M | 321M | 455M | 601M | 596M | 750M | 703M |
| Operating Income | 94.5M | 102M | 131M | 156M | 201M | 217M | 272M | 182M |
| EBITDA | 109M | 114M | 112M | 134M | 155M | 144M | 227M | 116M |
| Net Income | 58.7M | 52.6M | 81.4M | 102M | 107M | 66.8M | 118M | 68.6M |
| EPS | 0.74 | 0.66 | 1.03 | 0.97 | 1.02 | 0.63 | 1.09 | 0.49 |
| Balance Sheet | ||||||||
| Total Assets | 794M | 891M | 1.24B | 2.37B | 2.89B | 4.23B | 4.30B | 4.96B |
| Total Liabilities | 336M | 381M | 647M | 716M | 1.14B | 2.42B | 2.36B | 2.27B |
| Shareholders' Equity | 458M | 511M | 592M | 1.65B | 1.75B | 1.80B | 1.91B | 2.67B |
| Cash & Short-term Investments | 55.9M | 149M | 236M | 252M | 268M | 1.05B | 523M | 329M |
| Cash Flow | ||||||||
| Operating Cash Flow | -4.13M | 84.6M | 44.6M | -342M | -187M | 148M | -96.3M | - |
| Capital Expenditure | 2.01M | 3.80M | 6.53M | 125M | 547M | 112M | 59.3M | 64.8M |
| Free Cash Flow | -6.14M | 80.8M | 38.1M | -467M | -735M | 35.8M | -156M | -813M |
| Ratios | ||||||||
| ROE | 12.8% | 10.3% | 13.7% | 6.2% | 6.1% | 3.7% | 6.2% | 2.6% |
| ROA | 7.4% | 5.9% | 6.6% | 4.3% | 3.7% | 1.6% | 2.7% | 1.4% |
| Net Profit Margin | 9.7% | 6.9% | 9.5% | 8.6% | 6.7% | 3.9% | 5.2% | 2.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Wuhan Huakang Century Medical Co. Ltd. dividends
- Dividend yield
- 0.49%
- Forward dividend
- 0.20 CNY
- Payout ratio
- 16.4%
- Ex-dividend date
- May 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 19.3M | 0.18 | 16.4% |
| 2024 | CNY 31.2M | 0.30 | 46.8% |
| 2023 | CNY 23.0M | 0.22 | 21.5% |
| 2022 | CNY 11.6M | 0.11 | 11.3% |
| 2021 | CNY 5.01M | 0.06 | 6.2% |
| 2020 | CNY 6.66M | 0.08 | 12.7% |
| 2019 | CNY 1.98M | 0.02 | 3.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Wuhan Huakang Century Medical Co. Ltd.
- Insiders 38.73%
- Institutions 4.50%
- Public & others 56.77%
- Shares outstanding 139M
- Free float 68.0M
Wuhan Huakang Century Medical Co. Ltd. company profile
- Company name
- Wuhan Huakang Century Medical Co. Ltd.
- Ticker
- 301235.SHE
- ISIN
- CNE1000057D4
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 2,067
- Fiscal year end
- December
- Address
- Building 3, No. 718 Gaoxin Avenue, Wuhan, China, 430223
- Phone
- 86 27 8726 7611
- Website
- whhksj.com
About Wuhan Huakang Century Medical Co. Ltd.
Wuhan Huakang Century Clean Technology Co., Ltd. provides purification system integration and sale of medical equipment and consumables services in China and internationally. It is also involved in the sale of medical equipment and consumables. In addition, the company offers integrated medical, laboratory integrated, and integrated electronic cleaning services, as well as medical consumables sales; purification system integration operation, and maintenance services. The company was formerly known as Wuhan Huakang Century Medical Co., Ltd. and changed its name to Wuhan Huakang Century Clean Technology Co., Ltd. in March 2025. Wuhan Huakang Century Clean Technology Co., Ltd. was founded in 2008 and is headquartered in Wuhan, China.
Wuhan Huakang Century Medical Co. Ltd. management
5- Mr. Xinqiang XieGM & Director · born 1965
- Ms. Yingchao ZhangFinancial Director & Accounting Supervisor · born 1980
- Mr. Zhan PengDeputy GM & Secretary · born 1986
- Mr. Hai WangDeputy General Manager · born 1976
- Ms. Jiali WangDeputy General Manager · born 1977